|
tramadol tablet Dures tramadol tablet, 150 mg provided analgesia generally comparable to the combination of acetaminophen 650 mg with propoxyphene napsylate 100 mg tramadol tablet, with a tendency toward later peak effect. Ultram (tramadol hydrochloride) has been studied in three long-term controlled trials involving a total of 820 patients with 530 patients receiving Ultram. Patients with chronic conditions such as low back pain tramadol tablet, cancer tramadol tablet, neuropathic pain and orthopedic and joint conditions entered a double-blind phase of one to three months. Average daily doses of approximately 250 mg of Ultram in divided doses produced analgesia comparable with five doses of acetaminophen 300 mg with codeine phosphate 3 tramadol tablet.
tramadol tablet 0 mg (Tylenol® with Codeine 3) daily five doses of aspirin 325 mg with codeine phosphate 30 mg daily and with two to three doses of acetaminophen 500 mg with oxycodone hydrochloride 5 mg (Tylox®) daily. Following the double-blind period tramadol tablet, some patients took Ultram in an open period for up to two years. INDICATIONS Ultram is indicated for the management of moderate to moderately severe pain. CONTRAINDICATION Ultram should not be administered to patients who have previously demonstrated hypersensitivity to tramadol or in cases of acute intoxication with alcohol tramadol tablet, hypnotics tramadol tablet, centrally acting analgesics tramadol tablet, opioids or psychotropic drugs. WARNING Seizure Risk Tramadol causes seizures in animal models tramadol tablet, and a few seizures have been reported in humans receiving excessive single oral doses (700 mg) or large intravenous doses (300 mg). Administration of Ultram may enhance the seizure risk in patients taking MAO inhibitors tramadol tablet, neuroleptics tramadol tablet, other drugs that reduce the seizure threshold patients with epilepsy tramadol tablet, or patients otherwise at increased risk for seizure. In animal studies tramadol tablet, naloxone administration increased the risk of convulsions. Use with CNS Depressants Ultram should be used with caution and in reduced dosages when administered to patients receiving CNS depressants such as alcohol tramadol tablet, opioids tramadol tablet, anesthetic agents tramadol tablet, phenothiazin.
tramadol tablet Causes seizures in animal models tramadol tablet, and a few seizures have been reported in humans receiving excessive single oral doses (700 mg) or large intravenous doses (300 mg). Administration of Ultram may enhance the seizure risk in patients taking MAO inhibitors tramadol tablet, neuroleptics tramadol tablet, other drugs that reduce the seizure threshold patients with epilepsy tramadol tablet, or patients otherwise at increased risk for seizure. In animal studies tramadol tablet, naloxone administration increased the risk of convulsions. Use with CNS Depressants Ultram should be used with caution and in reduced dosages when administered to patients receiving CNS depressants such as alcohol tramadol tablet, opioids tramadol tablet, anesthetic agents tramadol tablet, phenothiazine.
tramadol tablet 
tramadol tablet | | | | | |
tramadol tablet
|
